{"nct_id":"NCT05239728","title":"A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2022-03-15","start_date_type":"ACTUAL","primary_completion_date":"2026-10-28","primary_completion_date_type":"ESTIMATED","completion_date":"2029-09-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}